NYLIM
EXAS

New York Life Investment Management’s Exact Sciences EXAS Stock Holding History

New York Life Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-65,142
Closed -$6.62M – 797
2025
Q4 		$6.62M Buy
65,142
+46,115
+242% +$3.7M 0.06% 270
2025
Q3 		$1.04M Sell
19,027
-313
-2% -$15.6K 0.01% 648
2025
Q2 		$1.03M Sell
19,340
-374
-2% -$19K 0.01% 637
2025
Q1 		$853K Sell
19,714
-648
-3% -$32.8K 0.01% 677
2024
Q4 		$1.14M Sell
20,362
-1,867
-8% -$116K 0.01% 634
2024
Q3 		$1.51M Buy
22,229
+333
+2% +$18.8K 0.01% 622
2024
Q2 		$925K Buy
21,896
+1,321
+6% +$72.7K 0.01% 699
2024
Q1 		$1.42M Sell
20,575
-531
-3% -$33.6K 0.01% 608
2023
Q4 		$1.56M Buy
21,106
+1,014
+5% +$66.5K 0.02% 584
2023
Q3 		$1.37M Buy
20,092
+10,223
+104% +$867K 0.01% 575
2023
Q2 		$927K Buy
+9,869
New +$770K 0.01% 604

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

New York Life Investment Management's EXAS Position: Q1 2026 in Review

New York Life Investment Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 65,142 shares — an estimated $6.62M sold.

New York Life Investment Management first reported a position in EXAS in Q2 2023 and held it in 11 quarters. The position peaked at $6.62M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • New York Life Investment Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • New York Life Investment Management sold 65,142 Exact Sciences shares in Q1 2026, an estimated $6.62M.
  • New York Life Investment Management first reported a position in Exact Sciences in Q2 2023 and held it in 11 quarters.
  • New York Life Investment Management's Exact Sciences position peaked at $6.62M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.